Most Popular White Papers
Bellwether Report .com is Bringing you the Latest on AVI Biopharma Inc.
M2 Presswire, August, 2006
 | Content provided in partnership with |  |
M2 PRESSWIRE-2 August 2006-bellwetherreport.com: Bellwether Report .com is Bringing you the Latest on AVI Biopharma Inc(C)1994-2006 M2 COMMUNICATIONS LTD RDATE:02082006 The Bellwether Report Takes Notice of AVI Biopharma Inc. (NASDAQ:AVII) AVI BioPharma (formerly Antivirals) develops therapeutic and gene-targeted treatments for cancer and heart disease.
Its lead products, NeuGene antisense drugs, block the function of certain genetic sequences to treat bone cancer and restenosis, a cardiovascular disease, as well as kidney and viral diseases. Biotech firm SuperGen bought ...
Read the rest of this article with a Free Trial at HighBeam Research.Find Research Guides for:
Find Featured Titles for: Business
- Academy of Marketing Science Review
- Accounting Historians Journal, The
- Accounting History
- AgExporter
- Agricultural Research
- Agricultural and Resource Economics Review
- Air Force Comptroller
- Air Safety Week
- Airline Industry Information
- American Demographics
- American Journal of Potato Research
- Architectural Review, The
- Asian Economic News
- Entrepreneur